Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome

Indian Heart Journal

Volumn 60, Issue 6, 2008, Pages 536-542

  Narain, V S ^b   Gupta, Nishant ^b   Sethi, Rishi ^b   Puri, Aniket ^b   Dwivedi, S K ^b   Saran, R K ^b   Puri, V K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b NONE

Author keywords

ACS; Acute coronary syndrome; Non st elevation myocardial infarction; NSTEMI

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; TROPONIN T;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; C-REACTIVE PROTEIN; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; RISK ASSESSMENT; STATISTICS AS TOPIC; TROPONIN T;

EID: 59949083863     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of admission electrocardiogram in acute coronary syndrome. JAMA 1999;281:707-713.
2. Antman EM, Cohen M, Bernink PJLM, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision-making. JAMA 2000;284:835-842.
3. Heidenreich PA, AlloggiamentoT, Melsop K, et al. The prognostic value of Trop-T in NSTEMI ACS: A meta analysis. J Am Coll Cardiol 2001;38:478-485.
4. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
5. Alpert JS, Thygesen K, Antman E, et al. The Joint European Society of Cardiology/American College of Cardiology committee. Myocardial infarction redefined-A consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
6. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003;108:275-281.
7. Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105:1760-1763.
8. Cynthia M, Yuling Fu, Lauer MS, Stefen James. Short and long term risk stratification in acute coronary syndrome. J Am Coll Cardiol 2006;48:939-947.
9. Palazzuoli A, Decker J, Calabro A. Brain natriuretic peptide and other risk markers for out come assessment in patients with non ST elevation coronary syndromes and preserved systolic function. Am J Cardiol 2006;98:1322-1328.
10. Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes: A TIMI 11B substudy. Am J Cardiol 2002;89:463-465.
11. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-1021.
12. Narain VS, Puri A, Gilhotra HS, et al. Third heart sound revisited: A correlation with NT proBNP & echo to detect left ventricular dysfunction. Indian Heart Journal 2005;57(1):31-34.
13. Puri A, Narain VS, Mehrotra S, Dwivedi SK, Saran RK, Puri VK. N terminal-pro brain natriuretic peptide predicts adverse outcomes in acute myocardial infarction even with preserved left ventricular ejection fraction. Indian Heart Journal 2006;58:138-143.
14. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of Creactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
15. Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol 2000; 35: 1535-1542.
16. Morrow DA, Rifai N, Altman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-1465.
17. Haverkate F, Thompson SG, Pyke SD, Gallimore RJ, Pepys MB. Production of C-reactive protein and the risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-466.